Clinical trial
A Study Exploring the Use of the Foundation Medicine Genomic Profiling Assay in a Phase I Solid Tumor Patient Population
NCT02437617 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study Exploring the Use of the Foundation Medicine Genomic Profiling Assay in a Phase I Solid Tumor Patient Population
- Lead sponsor
- M.D. Anderson Cancer Center
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 13, 2012
- Completion date
- June 1, 2021
- Enrollment
- 500 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
advanced cancers